Search clinical trials for: NVL-520

Total 4591 results

Nuvalent Inc.

Recruiting

A Study of NVL-520 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Metastatic Solid Tumor | Locally Advanced Solid Tumor

Canada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
NovaRock Biotherapeutics, Ltd

Recruiting

A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.

Advanced Malignant Tumors

China
Vedic Lifesciences Pvt. Ltd.

Recruiting

A Study to Evaluate the Efficacy of VL-NL-02 on Sleep Quality.

Mood and Sleep Quality

India
Navitor Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc.

Recruiting

Open-Label of SPN-820 in Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Yonsei University

Unknown

Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck

Head Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell Metastatic

Korea, Republic of
Nuvalent Inc.

Recruiting

A Study of NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Metastatic Solid Tumor | Locally Advanced Solid Tumor

United States, Australia, Taiwan, Spain, United Kingdom, France, Korea, Republic of, Canada, Singapore
University of Nottingham
University Hospitals of Derby and Burton NHS Foundation Trust

Completed

A Study of Agreement Between Oxygen Saturation Measured by Two Probes in Infants on the Neonatal Unit (Ag-OS)

Neonatal Disease

United Kingdom
NVP Healthcare

Recruiting

To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients

Cardiovascular Diseases

Korea, Republic of
University of Manitoba
innoVactiv Inc.

Completed

Efficacy of a Brown Seaweed Powder for Glycemic Control

Blood Glucose

Canada
NVP Healthcare

Completed

Pharmacokinetic Characteristics and Safety After Administration of NVP-2002

Healthy

Korea, Republic of
Boehringer Ingelheim

Completed

Relative Bioavailability of Different Oral Viramune Extended Release Formulations Compared to Viramune® Oral Suspension in Healthy Male Volunteers

Healthy
NVP Healthcare

Completed

Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2 (Navipharm)

Healthy

Korea, Republic of
NVP Healthcare

Completed

Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2

Healthy

Korea, Republic of
NVP Healthcare

Withdrawn

Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1603-1 and NVP-1603-2

Healthy
NVP Healthcare

Completed

Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain

Acute Low Back Pain

Korea, Republic of
NVP Healthcare

Completed

Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

Acute Low Back Pain

Korea, Republic of
Bausch Health Americas, Inc.

Completed

Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea (ADVENT)

HIV Associated Diarrhea

United States, Puerto Rico
Cytokinetics

Completed

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

United States
NVP Healthcare

Completed

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)

Healthy Volunteers

Korea, Republic of
Celgene

Completed

Safety and Pharmacokinetics of AVL-292 Following Multiple Doses and the Effect of Food on the Single-dose Pharmacokinetics of AVL-292

Healthy

United States
Taipei Medical University

Completed

Effects of PG2 on Fatigue-Related Symptom Clusters

Cancer-related Fatigue

Taiwan
NVP Healthcare

Completed

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)

Healthy Volunteers

Korea, Republic of
NVP Healthcare

Completed

Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2 (NVP-1805)

Healthy

Korea, Republic of
NVP Healthcare

Completed

Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects

Healthy Subjects

Korea, Republic of
NVP Healthcare

Completed

Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

Healthy Subjects

Korea, Republic of
NVP Healthcare

Completed

To Evaluate the Safety and the Pharmacokinetics of NVP-2203

Healthy Volunteers

Korea, Republic of
Vyluma, Inc.
Syneos Health

Active, not recruiting

CHAMP: Study of NVK-002 in Children With Myopia

Myopia

United States, Hungary, Ireland, Netherlands, Spain, United Kingdom
NVP Healthcare

Completed

A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402

Healthy

Korea, Republic of
POLYSAN Scientific & Technological Pharmaceutical...

Completed

"Unifuzol®" in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Russian Federation
Deutsches Herzzentrum Muenchen
EvidentIQ Germany GmbH; Institute of AI and Informatics in Medicine Technical... and other collaborators

Not yet recruiting

Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy (ISAR-WAVE)

Coronary Artery Disease

Germany
GlaxoSmithKline
Parexel

Completed

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. (AUSTRI)

Asthma

United States, Australia, Poland, Russian Federation, Spain, Ukraine, Germany, Bulgaria, Argentina, Peru, South Africa, Taiwan, Belgium, Italy, Hungary, Korea, Republic of, Austria, Romania, Colombia, Slovakia, United Kingdom, Mexico and more
Population Health Research Institute

Recruiting

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease (COMPLETE-2)

Coronary Artery Disease | Acute Myocardial Infarction

United States, Sweden, Denmark, Canada, United Kingdom, Germany, Italy
Clinical Research Center Kiel GmbH
Nofima

Completed

Glycemic Response to Two Doses of Low Sugar Apple Juice (HB-RCT2-2015)

Prediabetes

Germany
Boehringer Ingelheim

Completed

Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected Subjects

HIV Infections
Medtronic BRC
Medtronic

Completed

Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study (RARE-PEARL)

Permanent Atrial Fibrillation

Italy
Shockwave Medical, Inc.

Recruiting

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Myocardial Infarction | Coronary Artery Disease

United States
Arrowhead Pharmaceuticals

Withdrawn

Study of ARC-520 in Patient With Chronic Hepatitis B Virus

Chronic Hepatitis B

Australia
Duke University
National Heart, Lung, and Blood Institute (NHLBI); American Heart Association

Completed

Ketone Pharmacokinetic Study in HFrEF

Heart Failure With Reduced Ejection Fraction

United States
Göteborg University

Recruiting

The Effects of Objective Estimation of Pain Response

Pain, Acute | Anesthesia

Sweden
Eli Lilly and Company

Completed

Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma

Glioblastoma Multiforme

Germany
Cerevel Therapeutics, LLC

Recruiting

A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia

Schizophrenia

United States, Bulgaria, Hungary
Novavax

Active, not recruiting

Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines (COVID-19)

COVID-19

United States
Cerevel Therapeutics, LLC

Recruiting

A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy

Apathy in Dementia

United States, Canada
Singapore ETH Centre
Nanyang Technological University; ETH Zurich; National University of Singapore

Recruiting

The LvL UP Pilot Trial

Health Behavior | Noncommunicable Diseases | Mental Health Issue | Lifestyle Risk Reduction

Singapore
Fondazione GISE Onlus
University of Padova; Shockwave Medical, Inc.; INNOVA HTS SRL

Recruiting

The GISE (Società Italiana di Cardiologia Interventistica) - ShockCalcium Registry

Coronary Disease

Italy
NovalGen Ltd.

Recruiting

First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies

Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Non-small Cell Lung Cancer (NSCLC) | Small Lymphocytic Lymphoma | Malignant Melanoma | Chronic Lymphocytic Leukaemia

United Kingdom
Neuropharm

Completed

Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome

Fragile X Syndrome

United States
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy (CLMF237A1303)

Diabetes Mellitus, Type 2

Japan
PhytoHealth Corporation

Completed

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

Cancer-related Fatigue

Taiwan
Surakameth Mahasirimongkol
Chulalongkorn University; National Institutes of Health (NIH); Mahidol University and other collaborators

Completed

Genotype Based Personalized Prescription of Nevirapine (GENPART)

HIV Infections | HIV | AIDS | Nevirapine Induced Rash | Nevirapine Induced Hepatitis | Adverse Side Effects

Thailand

Search clinical trials for: NVL-520

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations